Sareum Holdings plc

15.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:SARHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (11.54%)
Div yield —
ROE (178.46%)
Biotechnology
Beta (5Y) (0.54)
PE TTM —
TSR TTM 11.11%
Mkt cap £24.54M
ROIC (87.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
19p
24.07%
(62.41%)
Buy 2|1|5|6|8
2Q26
3Q26
4Q26
1Q27
Earnings per share£
0.24
0.26
0.27
0.29
18.74%
22.48%
32.04%
35.26%
Revenue£M
1.283
1.283
1.358
1.398
3.82%
(1.39%)
6.23%
10.95%
Peers (US$33.02M)
Cap (US$)
PE
39.28M
—
27.68M
—
32.83M
—
Capital
TTM
5Y
10Y
Leveragex
0.278
0.764
0.648
EBIT/Intx
0.892
1.510
1.458
Own earn%
494.68
163.95
130.71
Sh yield%
30.79
32.18
30.06
Owners
Insiders/Inst%
13.54
68.06
Short interest%
1.32
SBC / revenue%
3.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
10